GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PT Merck Tbk (ISX:MERK) » Definitions » Price-to-Free-Cash-Flow

PT Merck Tbk (ISX:MERK) Price-to-Free-Cash-Flow : 14.30 (As of Oct. 09, 2024)


View and export this data going back to 1981. Start your Free Trial

What is PT Merck Tbk Price-to-Free-Cash-Flow?

As of today (2024-10-09), PT Merck Tbk's share price is Rp3720.00. PT Merck Tbk's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2024 was Rp260.21. Hence, PT Merck Tbk's Price-to-Free-Cash-Flow Ratio for today is 14.30.

The historical rank and industry rank for PT Merck Tbk's Price-to-Free-Cash-Flow or its related term are showing as below:

ISX:MERK' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 6.96   Med: 17.12   Max: 228.76
Current: 14.29

During the past 13 years, PT Merck Tbk's highest Price-to-Free-Cash-Flow Ratio was 228.76. The lowest was 6.96. And the median was 17.12.

ISX:MERK's Price-to-Free-Cash-Flow is ranked better than
69.57% of 506 companies
in the Drug Manufacturers industry
Industry Median: 23.775 vs ISX:MERK: 14.29

PT Merck Tbk's Free Cash Flow per Share for the three months ended in Jun. 2024 was Rp46.59. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was Rp260.21.

During the past 12 months, the average Free Cash Flow per Share Growth Rate of PT Merck Tbk was -16.80% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was 65.50% per year.

During the past 13 years, PT Merck Tbk's highest 3-Year average Free Cash Flow per Share Growth Rate was 120.00% per year. The lowest was -46.20% per year. And the median was 0.75% per year.


PT Merck Tbk Price-to-Free-Cash-Flow Historical Data

The historical data trend for PT Merck Tbk's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Merck Tbk Price-to-Free-Cash-Flow Chart

PT Merck Tbk Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 36.23 13.05 23.61 10.18

PT Merck Tbk Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.03 10.41 10.18 13.64 15.26

Competitive Comparison of PT Merck Tbk's Price-to-Free-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, PT Merck Tbk's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Merck Tbk's Price-to-Free-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PT Merck Tbk's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where PT Merck Tbk's Price-to-Free-Cash-Flow falls into.



PT Merck Tbk Price-to-Free-Cash-Flow Calculation

PT Merck Tbk's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=3720.00/260.209
=14.30

PT Merck Tbk's Share Price of today is Rp3720.00.
PT Merck Tbk's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp260.21.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

PT Merck Tbk  (ISX:MERK) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


PT Merck Tbk Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of PT Merck Tbk's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Merck Tbk Business Description

Traded in Other Exchanges
N/A
Address
Jalan T.B. Simatupang No. 8, Pasar Rebo, Jakarta Timur, IDN, 13760
PT Merck Tbk engages in the manufacture and sale of pharmaceutical products in Indonesia. The company operates in three segments: Biopharma, Consumer Health, and Others. The company offers pharmaceutical and biological prescription medicines for colorectal cancer, head and neck tumors, multiple sclerosis, infertility, growth hormone disorders, cardiovascular disorders, diabetes, as well as thyroid disorders such as hypothyroidism.

PT Merck Tbk Headlines

No Headlines